U. S. SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549

 


 

FORM 10-Q

 

(Mark One)

 

 

ý

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2005

 

 

o

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

 

 

For the transition period from       to       

 

 

Commission File Number: 001-15667

 

 

PRECIS, INC.
(Name of business issuer in its Charter)

 

OKLAHOMA

 

73-1494382

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

 

2040 North Highway 360
Grand Prairie, Texas 75050

(Address of principal executive offices)

 

(866) 578-1665

(Issuer’s telephone number)

 

 

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ý  No  o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

 

 

Yes o No ý

 

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS

 

Indicate by check mark whether the registrant filed all documents and reports required to be filed by Section 12, 13 or
15(d) of the Exchange Act after the distribution of securities under a plan confirmed by a court.         Yes  
o  No  o

 

APPLICABLE ONLY TO CORPORATE ISSUERS

 

State the number of shares outstanding of each of issuer’s classes of common equity, as of the latest practicable date:  As of May 13, 2005, 12,332,316 shares of the issuer’s common stock, $0.01 par value, were outstanding.

 

 



 

PRECIS, INC.

FORM 10-Q
For the Quarter Ended March 31, 2005

 

TABLE OF CONTENTS

 

Part I.

Financial Information

3

 

 

 

Item 1.

Financial Statements (Unaudited)

3

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

3

 

 

 

Item 3.

Quantitative and Qualitative Disclosure of Market Risk

10

 

 

 

Item 4.

Controls and Procedures

10

 

 

 

Part II.

Other Information

11

 

 

 

Item 1.

Legal Proceedings

11

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

13

 

 

 

Item 3.

Defaults Upon Senior Securities

14

 

 

 

Item 4.

Submission of Matters to a Vote of Security Holders

14

 

 

 

Item 5.

Other Information.

14

 

 

 

Item 6.

Exhibits

15

 

 

 

SIGNATURES

16

 

2



 

Part I.              Financial Information

 

Item 1.           Financial Statements (Unaudited)

 

Our financial statements which are prepared in accordance with Regulation S-X are set forth in this report beginning on page 18.

 

Item 2.           Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion is qualified in its entirety by the more detailed information in our Form 10-K and the financial statements contained in this report, including the notes thereto, and our other periodic reports filed with the Securities and Exchange Commission since December 31, 2004 (collectively referred to as the “Disclosure Documents”). Certain forward-looking statements contained herein and in such Disclosure Documents regarding our business and prospects are based upon numerous assumptions about future conditions that may ultimately prove to be inaccurate and actual events and results may materially differ from anticipated results described in such statements.  Our ability to achieve such results is subject to the risks and uncertainties discussed in our Form 10-K.  Any forward-looking statements contained in this report represent our judgment as of the date hereof.  We disclaim, however, any intent or obligation to update these forward-looking statements. As a result, the reader is cautioned not to place undue reliance on these forward-looking statements.

 

Consumer Healthcare Savings Solution

 

We offer savings on healthcare services throughout the United States to persons who are uninsured, under-insured, or have elected to purchase only high deductible or limited benefit medical insurance policies. These savings are achieved by accessing the same preferred provider organizations (PPOs) that are utilized by many insurance companies. These programs are sold primarily through a network marketing strategy under the name Care Entrée™. We design these programs to benefit healthcare providers as well as the network members. Providers commonly give reduced or preferred rates to PPO networks in exchange for steerage of patients. However, the providers must still file claim forms and wait 30 to 60 days to be paid for their services. Our programs utilize these same networks to obtain the same savings for the Care Entrée™ program members. However, the healthcare providers are paid much more promptly without the oversight of the typical claims review processes of an insurance company. We provide transaction facilitation services to both the program member and the healthcare provider.

 

 We also offer full third party administration services through our wholly-owned subsidiary, Access HealthSource, Inc., (“Access”).  Access helps us offer a more complete suite of healthcare services. We are now able to provide individuals and employee groups access to preferred provider networks, medical escrow accounts and full third party administration capabilities to adjudicate and pay medical claims.  We acquired Access in the second quarter of 2004 and its results of operations have contributed favorably to our consolidated results.  Access has successfully secured multi-year contracts on favorable terms with its two largest clients and has brought us a stable source of revenue.  Moreover, we have realized certain intangible benefits from the acquisition.  For instance, we have broadened the management responsibilities of several members of Access’ management team to company-wide roles.  Our new Chief Operating Officer, Frank Apodaca, is the President and C.E.O. of Access and he will be implementing, on a company-wide basis, operational controls that have been successful at Access.

 

Affordable Healthcare Insurance and Financial Products

 

Commencing in September 2003, through our subsidiary, Care Financial of Texas, L.L.C. (“Care Financial”), we began offering our high deductible and scheduled benefit insurance policies. In addition, we have recently added a suite of products including life insurance and annuities, along with health savings accounts (HSAs), Healthcare Reimbursement Arrangements (HRAs) and medical and dependent care Flexible Spending Accounts (FSAs) offered through Care125, a division of our Foresight, Inc. subsidiary (“Foresight”). The high deductible and scheduled benefit insurance policies, HSAs, HRAs and medical and dependent care FSAs, when combined with the Care Entrée™ program, offer affordable, well-rounded solutions for individuals and employers who are no longer able to afford or obtain traditional health insurance policies. While these products are usually sold by licensed life and health insurance agents, the HRAs and medical and dependent care FSAs are also sold by our independent marketing representatives who, from a regulatory standpoint, are not required to be licensed to sell these products. The life insurance products serve to complement our healthcare product offerings by addressing our members’ overall financial condition. The insurance policies are sold through our independent marketing representatives who are licensed insurance agents and other licensed agents who are not Care Entree independent marketing representatives.

 

3



 

Our Group and Wholesale Products

 

We offer three wholesale membership service solutions:

 

Private Label and Co-Brand Healthcare Programs

 

We design and offer healthcare membership programs for employer groups, retailers and association-based organizations. These programs are marketed under our “For Your Good Health” label or the privately labeled name of our client. Membership in these programs are offered and sold by direct sales or through marketing companies that ask prospective customers to call a customer service center for more information (in-bound direct marketing). We believe that our clients, their members, and the vendors of the products and services offered through the programs, all benefit from our membership service programs. The products and services are bundled, priced and marketed utilizing relationship marketing strategies or inbound direct marketing to target the profiled needs of the clients’ particular member base.

 

Repricing for Governments and Other Self-Funded Employers

 

For governments and other large, self-funded employers seeking to reduce the cost of offering healthcare benefits to their employees, we can also offer a more streamlined version of our product. In these cases, we offer access to healthcare through our network of providers and the efficient repricing of bills through our proprietary systems. We offer these services for a price based on either the number of participants per month or as a percentage of savings on healthcare costs actually realized.

 

On June 18, 2004, we acquired Access, a full-service third party administrator, for a purchase price of $3,666,000, consisting of $2,000,000 of cash and $1,400,000 of our common stock (488,486 shares) and $266,000 of acquisition cost including investment banking, valuation and legal and accounting fees.  Additional obligations under that purchase agreement are based on future performance of Access and during the first quarter of 2005, Access’ performance to date resulted in an obligation to convey cash payments of $560,000 plus the issuance of 320,473 common shares valued at $560,000, which were conveyed in April.  Through the acquisition of Access, we now provide a wide range of healthcare claims administration services and other cost containment procedures that are frequently required by governments and other large employers who have chosen to self fund their healthcare benefits requirements. Access helps us offer a more complete suite of healthcare services.  Also through Access, we provide individuals and employee groups access to preferred provider networks, medical escrow accounts and full third party administration capabilities to adjudicate and pay medical claims.  From a sales distribution standpoint, we have the ability to grow Access’ regional business through our numerous independent marketing representatives who sell both to individuals and employer groups throughout the United States.  Our acquisition of Access serves to complement our entry into the public sector market through our agreement with the State of Louisiana in 2003.  Access’ primary area of expertise is in the public sector market.

 

Non-healthcare Related Club Membership Programs

 

Through Foresight, we also design non-healthcare related membership programs for rental-purchase companies, financial organizations, employer groups, retailers and association-based organizations. Memberships in these programs are also offered and sold as part of a point-of-sale transaction or by direct marketing through direct mail or as an insert. Program members are offered and provided with our and third-party vendors’ products and services. The products and services are bundled, priced and marketed to target the profiled needs of the clients’ particular customer base. Among the products and services offered are (i) consumer product extended warranties, (ii) tire and wheel guarantee, (iii) insurance products included as association benefits, (iv) emergency travel and living expense reimbursement, (v) access to air ambulance evacuation services, (vi) identity theft protection, (vii) savings on veterinary care, (viii) retail and entertainment discounts, (ix) grocery coupons,  (x) a retail savings coupon book, (xi) emergency roadside assistance, and (xii) auto deductible expense reimbursement. Substantially all of our non-healthcare related membership service programs are offered and sold at retail by clients engaged in the rental-purchase industry.

 

Critical Accounting Policies

 

Revenue Recognition

 

Healthcare Membership Revenues

 

The Company recognizes membership revenues, other than initial enrollment fees, on each monthly anniversary date. Membership revenues are reduced by the amount of refunds estimated to be incurred.  For members that are billed directly, collection of the billed amount is collected almost entirely by automated clearinghouse, electronic check or by electronic charge to the members’ credit card. The settlement of those charges occurs within a day or two. In a minority of

 

4



 

cases, the membership fees may be billed to the member by our private label partners, and then our portion of such revenue is remitted to us on a periodic basis. During the time from the billing of such member fees and their remittance to us, we record a receivable from those private label partners, for which management must estimate an allowance for uncollectible accounts.  We review the aging of outstanding balances, the credit worthiness of the private label partner and their history of paying amounts owed as agreed in estimating that allowance.

 

Member enrollment fees, net of direct costs, are deferred and amortized over the estimated membership period, which averages eight to ten months. Independent marketing representative fees, net of direct costs, are deferred and amortized over the term of the contract. Judgment is involved in the allocation of costs to determine the direct costs netted against those deferred revenues, as well as in estimating the membership period over which to amortize such net revenue. The Company maintains analysis of such costs and collects statistics on such membership periods as a basis for adjusting these estimates from time to time.

 

Access Third Party Administration

 

Access recognizes revenue based upon the individual contract arrangements that it has with each of its’ clients, i.e., when the contractual obligations are satisfied.

 

Rental Purchase and Club Membership Revenues

 

Rental purchase and club membership revenues are recognized in the month that our products and services have been delivered to our clients. We sell rental purchase and club membership programs on a wholesale basis to our clients. The wholesale client remits a portion of the rental purchase and club membership revenues to us and retains the balance as compensation for having made the sale. We provide an allowance for those accounts that we consider to be uncollectible.

 

Commission Expense

 

Commissions are paid to our independent marketing representatives in the month following the month in which a member has enrolled in our Care Entrée™ program. Commissions are only paid in the following month when the related monthly membership fees have been received. We do not pay advanced commissions on membership sales. The amounts of commission are based upon established commission schedules and are determined and accrued based upon the recognition the related healthcare membership revenue, as described above.

 

Acquisitions

 

During 2004, we acquired Access for a total initial purchase price of $3,666,000.   Under the purchase obligation, the purchase price of Access could be increased if Access were to achieve certain performance thresholds.   Contingent consideration of $1,120,000 was accrued at March 31, 2005, based upon Access’ performance to date, increasing goodwill by that amount during the first quarter of 2005.  The allocation of $3,424,000 to goodwill is considered appropriate, as Access strategically complements the Company’s healthcare service offering.

 

Fixed Assets

 

Property and equipment are carried at cost less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method over the estimated useful lives of the related assets for financial reporting purposes. Leasehold improvements are depreciated using the straight-line method over their estimated useful lives or the lease term, whichever is shorter. The estimation of useful lives involves judgment and is based, in part, upon past experience with similar assets and upon management’s plans for the utilization of assets in the future.

 

We periodically review fixed assets, including software, whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable or their depreciation or amortization periods should be accelerated. When any such impairment exists, the related assets will be written down to their fair value. If we determine that the remaining useful life, based upon current events and circumstances, should be adjusted, the depreciation or amortization of the related asset is adjusted on a prospective basis.

 

Intangible Asset Valuation

 

Our intangible assets, consisting primarily of goodwill of $22,501,000 as of March 31, 2005, represented the excess of acquisition costs over the fair value of net assets acquired. Goodwill is not amortized. During the year ended December 31, 2004, our intangible assets were reduced by $2,000,000 to reflect impairment of the goodwill arising from our acquisition of

 

5



 

Foresight, Inc. in 2000 and were increased by $2,304,000 to reflect the goodwill arising from our acquisition of Access and by $1,400,000 allocated to a contract acquired in the acquisition of Access.   An additional increase of $1,120,000 occurred during the first quarter of 2005 as the result of the Access contingent consideration discussed above.

 

Income Taxes

 

Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to differences between the basis of assets and liabilities for financial and income tax reporting. The net deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. We evaluate the probability of recognizing the benefit of deferred tax assets through the reduction of taxes otherwise payable in the future and provide an allowance against the carrying amount of such deferred tax assets if it is more probable than not that some or all of those assets will not be realized.

 

Results of Operations

 

Current and Comparative Prior Period Historical Information.  The following table sets forth selected results of operations for the three months ended March 31, 2005 and 2004.

 

 

 

For the Three Months Ended
March 31,

 

 

 

Unaudited

 

(Dollars in Thousands except earnings per share)

 

2005

 

2004

 

Product and service revenues

 

$

8,700

 

$

9,946

 

Operating expenses:

 

 

 

 

 

Cost of operations

 

3,109

 

3,301

 

Sales and marketing.

 

2,200

 

3,198

 

General and administrative

 

3,485

 

2,329

 

 

 

 

 

 

 

Total operating expenses.

 

8,794

 

8,828

 

Operating income (loss)

 

(94

)

1,118

 

 

 

 

 

 

 

Other income and expenses:

 

 

 

 

 

Interest (income) and expense, net

 

(13

)

29

 

 

 

 

 

 

 

Total other expenses

 

(13

)

29

 

 

 

 

 

 

 

(Loss) earnings before income taxes

 

(81

)

1,089

 

(Benefit) provision for income taxes

 

(30

)

483

 

 

 

 

 

 

 

Net (Loss) earnings

 

$

(51

)

$

606

 

 

 

 

 

 

 

(Loss) earnings per common share:

 

 

 

 

 

Basic

 

$

0.00

 

$

0.05

 

 

 

 

 

 

 

Diluted (1) 

 

$

0.00

 

$

0.05

 

 

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

 

 

Basic.

 

11,824,255

 

11,864,714

 

 

 

 

 

 

 

Diluted (1)

 

11,824,255

 

11,930,725

 

 


(1)                                  For the quarter ended March 31, 2005, 16,391 shares related to outstanding stock options were not included in the calculation of fully diluted earnings per share because the inclusion would have been anti-dilutive.

 

6



 

Operational Review for the Three Months Ended March 31, 2005

 

Our healthcare membership base was approximately 52,000 members as of March 31, 2005 as compared to 79,000 members as of March 31, 2004, a decrease of approximately 27,000 members or 34.2%. The reduction in our healthcare membership base was primarily due to the implementation of the escrow account requirements for hospitalized care in the fourth quarter of 2002, and expansion to physicians and doctors commencing on October 1, 2003.   As of March 31, 2005, the percentage of our individual members who have escrowed funds with us was approximately 36.3% of the total individual healthcare membership base. This excludes our private label programs, where the escrow requirements have not been mandated.  In addition, our healthcare savings program has experienced issues with provider acceptance in some markets.  As a result, revenues from our healthcare savings program continue to decline by $3,227,000, from $9,583,000 in the first quarter of 2004 to $6,356,000 in the first quarter of 2005.

 

Although these escrow requirements negatively impacted our membership base and consequently our revenues and net earnings in 2004 and the first quarter of 2005, these changes were required to help provide assurance of payment to the healthcare providers and accordingly, their continued willingness to provide healthcare services to our members. This strategic move was critical to our long-term operational and financial viability in the health card savings market as many healthcare providers throughout the United States will no longer accept a “health discount” card. The success of our new healthcare product offering has not been fully determined. Therefore, its long-term impact on both revenues and net earnings is currently unknown and may not be known for some time. The growth of our members’ escrow or cash-in-trust to $5,349,000 as of March 31, 2005 from $4,922,000 as of December 31, 2004 and from $4,019,000 as of March 31, 2004, provides an indication that, while overall membership numbers have continued to decline, those members who do participate in the escrow-based form of our healthcare savings program are continuing to grow their escrow deposits with us.

 

Our operating results did benefit from the acquisition of Access, which occurred in June of 2004.   Access contributed $2,010,000 or 23.1% of first quarter 2005 revenue and $446,000 of net earnings (after taxes) to partially offset our other losses. Access has successfully secured multi-year contracts on favorable terms with its two largest clients and has brought us a stable source of revenue.  Moreover, we have realized certain intangible benefits from the acquisition.  For instance, we have broadened the management responsibilities of several members of Access’ management team to company-wide roles.  Our new Chief Operating Officer, Frank Apodaca, is the President and C.E.O. of Access and he will be implementing, on a company-wide basis, operational controls that have been successful at Access.

 

In the first quarter of 2005, we have undertaken measures and initiatives to improve our operating performance.  These measures and initiatives include (i) the integration of Access management members with our management team, as mentioned above, (ii) the termination of certain equipment capital leases, (iii) other cost reduction actions, and (iv) exploration of additional products to compliment our core healthcare savings product and offer additional compensatory incentives to our independent marketing representatives.

 

Comparison of the Three Months Ended March 31, 2005 and 2004

 

Product and Service Revenues.  During the three months ended March 31, 2005, revenues were $8,700,000, a decrease of $1,246,000 or (12.5%), from $9,946,000 during the comparable 2004 period.  The reduction in actual revenues for the three months ended March 31, 2005 from the corresponding period in 2004 was primarily due to continuing reductions in the members in our Care Entrée program of $3,227,000, from $9,583,000 in the first quarter of 2004 to $6,356,000 in the first quarter of 2005 as a result of our implementation of member escrow account requirements commencing in the fourth quarter of 2002, offset in part by revenues of $2,010,000 from Access that was acquired in June 2004.   The requirement of member escrow deposits was in response to market changes in the healthcare savings industry.  In addition, effective October 1, 2003, the escrow account requirements were expanded to include all doctors and physicians.  Under the escrow arrangement, we pre-certify to the provider the members’ ability to pay based upon the available escrow account/balances and to process the members’ payments directly to the providers to help assure timely payment to the providers.  As a result of these changes, we believe an enhanced healthcare product offering has been created for members and the healthcare providers. The overall success and impact on revenues and net earnings of this newly restructured product offering will not be known for sometime.  The escrowed funds referred to as cash-in-trust on our balance sheet were $5,349,000 as of March 31, 2005. Through the acquisition of Access, we provide a wide range of healthcare claims administration services and other cost containment procedures that are frequently required by governments and other employers who have chosen to self fund their healthcare benefit requirements.  For 2005, more than 65.8% of our revenues were attributable to our healthcare membership program.

 

Additionally, revenue in our Foresight wholesale club membership programs declined by $28,000, or 12.0%, from $234,000 in the first quarter of 2004 to $206,000 in the first quarter of 2005 due to the maturity and competitive nature of this business.  Revenue from our Care Financial division increased $25,000, or 27.8%, from $90,000 in the first quarter of 2004 to $115,000 in the first quarter of 2005.

 

7



 

Operating Metrics

 

Our healthcare membership base was approximately 52,000 members as of March 31, 2005 as compared to 79,000 members as of March 31, 2004, a decrease of approximately 27,000 members or 34.2%.  During the first quarter of 2005, our membership declined by 5,000 members or 8.8% from 57,000 members at December 31, 2004.  The reduction in our healthcare membership base was due to the implementation of the escrow account requirements in 2002 and 2003.  During the first quarter of 2005, we commenced development of a new product line consisting of health-related nutraceuticals, which are expected to generate an increasing stream of revenue later in 2005 and synergistically support resumption of growth in healthcare savings program revenue.

 

Cost of Operations.  Cost of operations for the three months ended March 31, 2005 decreased $192,000 or (5.8)%, to $3,109,000 from $3,301,000 during the 2004 comparable period.   Cost of operations was approximately 35.7% of revenues during the three months ended March 31, 2005, while during the comparable 2004 period cost of operations was 33.2% of revenues.  The decrease in cost of operations for the first quarter of 2005 was primarily due to decreases in costs of $736,000 related to decreased revenue in our Care Entree program discussed previously, offset by increased costs of $627,000 that is due to the acquisition of Access in June 2004.  The increase in cost of operations expense as a percentage of revenue was primarily attributable to increased preferred provider costs as a result of several ancillary products introduced after the first quarter of 2004, additional processing costs attributed to the administration of the escrow accounts and claims processing and the cost of capital leases of printing equipment entered into when membership level and enrollment activity was at a significantly higher level.

 

Sales and Marketing Expenses.  Sales and marketing expenses decreased $998,000 or 31.2%, to $2,200,000 during the three months ended March 31, 2005 from $3,198,000 during the comparable 2004 period.  Sales and marketing expenses represented 25.3% and 32.2% of revenues for the three months ended March 31, 2005 and 2004, respectively.  The decrease in sales and marketing expenses during the first quarter of 2005 is primarily due to decreases in commissions related to the decreased revenue in the Care Entree program discussed previously.  The decrease in sales and marketing expenses as a percentage of revenues is due in part to a shift toward private label sales of our healthcare membership product from 2004 to 2005.

 

General and Administrative Expenses.  General and administrative expenses increased $1,156,000 or 49.6%, to $3,485,000 during the three months ended March 31, 2005 from $2,329,000 during the comparable 2004 period.  General and administrative expenses represented 40.1% and 23.4% of revenues for the three months ended March 31, 2005 and 2004, respectively.  The increase in general and administrative expenses for the three months ended March 31, 2005 from the corresponding period in the prior year was primarily due to the acquisition of Access in June 2004 which resulted in an increase of $916,000 in general and administrative expenses in the first quarter of 2005.  Additionally, the increased expenses include $150,000 of additional depreciation expense resulting from an October 1, 2004 adjustment of the estimated useful life of certain internal-use software.

 

Total Operating Expenses.  During the three months ended March 31, 2005, total operating expenses (consisting of cost of operations, sales and marketing expenses, and general and administrative expenses) decreased $34,000 or 0.4%, to $8,794,000 from $8,828,000 during the comparable 2004 period.  Total operating expenses represented approximately 101.1% and 88.8% of revenues for the three months ended March 31, 2005 and 2004, respectively.  The decrease in operating margins from the first quarter of 2004 to the first quarter of 2005 was due to the reasons described above.  Also, total operating expenses for the first quarter of 2005 included accrued severance payments of $225,000 ($100,000 in general and administrative expenses and $125,000 in sales and marketing expenses) for terminated personnel, related to our enhanced cost containment measures.

 

Operating Income and Net Earnings.  During the three months ended March 31, 2005, our operating loss was $94,000, a decrease of $1,212,000 or 108.4%, from $1,118,000 during the comparable 2004 period.    The net loss applicable to common shareholders was $51,000, or 0.6% of revenues, net of a benefit for income taxes of $30,000.  In comparison, during the three months ended March 31, 2004, net earnings applicable to common shareholders were $606,000 or 6.1% of revenues, net of provision for income taxes of $483,000.  During the three months ended March 31, 2005, our earnings (loss) per common share calculated on a diluted basis was $0.00 per share compared to earnings per common share $0.05 from the comparable 2004 period.  Net loss applicable to common shareholders and net loss per common share calculated on a diluted basis for the three months ended March 31, 2005 were impacted by the net cost increases, and by the reduction in revenues, as previously described.  For the quarter ended March 31, 2005, 16,391 shares related to outstanding stock options were not included in the calculation of fully diluted earnings per share because the inclusion would have been anti-dilutive.

 

8



 

Recent Management Initiatives.  Benefiting from a seasonal trend which has been apparent in previous years, revenues increased slightly from revenues of $8,678,000 in the fourth quarter of 2004 to $8,700,000 in the first quarter of 2005, primarily due to resumption of spending habits by consumer customers, who may have forgone membership payment to us during the fourth quarter holiday season. It is not likely that this trend indicates a slowing of Care Entrée program membership and revenue, and such revenue may continue to decline in the future.

 

During the fourth quarter of 2004 and the first quarter of 2005, our management launched additional initiatives directed at reversing the decline in revenues and achieving a decrease in expenses. These measures and initiatives include (i) the integration of Access management members with our management team, as mentioned above, (ii) the termination of certain equipment capital leases, (iii) other cost reduction actions, and (iv) exploration of additional products to compliment our core healthcare savings product and offer additional compensatory incentives to our independent marketing representatives. While it is too early to fully assess the results of these initiatives, we can see some preliminary results. Cost of operations decreased $1,610,000 or 34.1% from the fourth quarter of 2004.  This decrease results primarily from the recognition in the fourth quarter of 2004 of provisions for uncollectible accounts and notes of $1,012,000 compared to $24,000 of provision in the first quarter of 2005. Sales and marketing expenses were virtually flat when compared to $2,210,000 in the fourth quarter of 2004. General and administrative expenses declined $910,000 or 20.7% from the fourth quarter of 2004, which included charges of $188,000 for accrual of expected costs to defend and settle pending litigation, as well as a number of smaller charges that did not recur in the first quarter of 2005. Total operating expenses decreased $4,531,000 or 34.0% to the first quarter of 2005 from the fourth quarter of 2004, which included an impairment charge of $2,000,000 on goodwill associated with the Foresight non-healthcare membership programs as well as the provision for uncollectible accounts and notes of $1,012,000 as described above.  Also, total operating expenses for the first quarter of 2005 included accrued severance payments of $225,000 for terminated personnel, related to our enhanced cost containment measures. Our operating loss of $94,000 for the first quarter of 2005 is a decrease of $4,482,000 or 96.4% from the fourth quarter of 2004, which included the provision for uncollectible accounts and notes, the goodwill impairment charge and other charges discussed above.

 

Income Tax Provision

 

SFAS 109, Accounting for Income Taxes, requires the separate recognition, measured at currently enacted tax rates, of deferred tax assets and deferred tax liabilities for the tax effect of temporary differences between the financial reporting and tax reporting bases of assets and liabilities, and net operating loss carryforwards for tax purposes. A valuation allowance must be established for deferred tax assets if it is “more likely than not” that all or a portion will not be realized. At March 31, 2005 and December 31, 2004, we had deferred tax benefits of $1,827,000 and $1,801,000, respectively, resulting in large part from net operating loss carryforwards which, if not utilized, will expire at various dates through 2020. The cumulative net deferred tax asset as of March 31, 2005 and December 31, 2004 was $1,172,000 and $1,146,000, respectively.  If we continue to incur net operating losses, a valuation allowance will be established. A valuation allowance adjustment will have a direct impact on net income (loss) in the amount of the allowance.

 

Liquidity and Capital Resources

 

Operating Activities.  Net cash provided by operating activities for the three months ended March 31, 2005 and March 31, 2004 was $120,000 and $1,443,000, respectively, a decrease of $1,323,000.   The decrease in net cash provided by operating activities for the three months ended March 31, 2005 is due primarily to the reduced net earnings during the period and decrease income taxes payable.

 

Investing Activities.  Net cash used in investing activities for the three months ended March 31, 2005 and 2004 was $38,000 and $152,000, respectively, and related primarily to purchase of fixed assets necessary to accommodate and support our operations.

 

Financing Activities.  Net cash used in financing activities for the three months ended March 31, 2005 was $447,000 as compared to the three months ended March 31, 2004 of $366,000.  During the three months ended March 31, 2005, net cash used in financing activities was primarily for payments on capital leases of $283,000 and repurchase of the Company’s common stock of $164,000.

 

At March 31, 2005 and December 31, 2004, we have working capital of $5,468,000 and $6,345,000, respectively. Other than our capital lease obligations of $799,000, we do not have any capital commitments. We do not anticipate that our capital expenditures for the remainder of the year ending December 31, 2005 will exceed the amount incurred during the comparable 2004 period.  We believe that our existing cash and cash equivalents, and cash provided by operations will be sufficient to fund our normal operations and capital expenditures for the next 12 months.

 

9



 

Because our capital requirements cannot be predicted with certainty, including any proposed business acquisitions for the remainder of the year ending December 31, 2005, there is no assurance that we will not require any additional financing during the next 12 months, and if required, that any additional financing will be available on terms satisfactory to us or advantageous to our shareholders.

 

Stock Repurchase Plan

 

On July 8, 2004, our Board of Directors authorized the repurchase of up to 500,000 shares of our common stock through open market or private purchase transactions over the next year depending on prevailing market conditions.  As of the filing of this report, we have purchased 473,423 shares under this authorization for a total consideration of $1,018,525 at a weighted average price of $2.15 per share.  Given the current interest rate environment, the nature of other available investments and our expected cash flows, we believe that purchasing our common stock shares enhances stockholder value.  Any additional treasury stock purchases will be made at prices that we consider attractive and at such times that we believe will not unduly impact our liquidity.  During the first quarter of 2005 and through May 13, 2005, repurchases of shares were as follows:

 

Month

 

Quantity
Purchased

 

Weighted
Avg. Stock
Price/Share

 

Total Cost

 

January

 

 

15,412

 

$

2.09

 

$

32,137

 

February

 

 

29,115

 

$

2.23

 

65,053

 

March

 

 

35,450

 

$

1.91

 

67,722

 

April

 

 

32,600

 

$

1.77

 

57,724

 

May

 

 

104,900

 

$

1.09

 

114,454

 

 

 

 

 

 

 

 

 

 

As of May 13, 2005

 

 

473,423

 

$

2.15

 

$

1,018,525

 

 

Cautionary Statement Relating to Forward Looking Information

 

We have included some forward-looking statements in this section and other places in this report regarding our expectations.  These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements, or industry results, to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  Some of these forward-looking statements can be identified by the use of forward-looking terminology including “believes,” “expects,” “may,” “will,” “should” or “anticipates” or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategies that involve risks and uncertainties.  You should read statements that contain these words carefully because they:

 

                  Discuss our future expectations;

 

                  Contain projections of our future operating results or of our future financial condition; or

 

                  State other “forward-looking” information.

 

We believe it is important to discuss our expectations; however, it must be recognized that events may occur in the future over which we have no control and which we are not accurately able to predict.  Readers are cautioned to consider the specific business risk factors described in our annual report on Form 10-K for the fiscal year ended December 31, 2004 and our Schedule 14A Proxy Statement for our 2004 annual shareholders meeting, and not to place undue reliance on the forward-looking statements contained herein, which speak only as of the date hereof.  We undertake no obligation to publicly revise forward-looking statements to reflect events or circumstances that may arise after the date hereof.

 

Item 3.           Quantitative and Qualitative Disclosures About Market Risk

 

We do not have any investments in market risk sensitive instruments.

 

Item 4.           Controls and Procedures

 

Our Chief Executive Officer and Chief Financial Officer are responsible primarily for establishing and maintaining disclosure controls and procedures designed to ensure that information required to be disclosed in our reports filed or

 

10



 

submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the U.S. Securities and Exchange Commission. These controls and procedures are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Furthermore, our Chief Executive Officer and Chief Financial Officer are responsible for the design and supervision of our internal controls over financial reporting that are then effected by and through our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. These policies and procedures

 

                                          pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

 

                                          provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and

 

                                          provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.

 

In connection with our year-end close process and the preparation of our Annual Report on Form 10-K as of December 31, 2004, an evaluation was performed under the supervision and with the participation of the Company’s management, including the CEO and CFO, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. Based on that evaluation as of December 31, 2004, the CEO and CFO had concluded that the Company’s controls suffered from a material weakness, in that losses were probable in the collection of outstanding accounts and notes receivable but those losses had not been adequately quantified or provided for in the allowance for doubtful accounts.  In the period from March 31, 2005 and the date of this report, the Company implemented improved procedures and controls to remediate that weakness. The CEO and CFO have concluded that although procedures were not completely formalized, in their entirety, as of March 31, 2005, they have analyzed accounts receivables and related allowances as of March 31, 2005 in the period since that date and therefore concluded that these balances are fairly stated as of March 31, 2005.  Our management reported to our auditors and the audit committee of our board of directors that, other than the changes to partially remediate significant deficiencies previously identified, no other change in our disclosure controls and procedures and internal control over financial reporting occurred during the first quarter of 2005 that would materially affect or was reasonably likely to materially affect our disclosure controls and procedures or internal control over financial reporting. In conducting their evaluation of our disclosure controls and procedures and internal controls over financial reporting, our management, including our Chief Executive Officer and Chief Financial Officer, did not discover any fraud that involved management or other employees who have a significant role in our disclosure controls and procedures and internal controls over financial reporting. Furthermore, there were no significant changes in our disclosure controls and procedures, internal controls over financial reporting, or other factors that significantly affect our disclosure controls and procedures or internal controls over financial reporting subsequent to the date of their evaluation, other than the enhanced procedures that are related to accounts receivables as described above.

 

Changes to Internal Control over Financial Reporting

 

During the first quarter of 2005, management recognized the need to improve its internal controls over financial reporting in as much as losses were probable in the collection of outstanding accounts and notes receivable but those losses had not been adequately quantified or provided for in the allowance for doubtful accounts.  In the period from March 31, 2005 and the date of this report, the Company implemented improved procedures and controls to remediate that weakness, including evaluation of the adequacy of the allowance for doubtful accounts by the CEO, CFO and Audit Committee of the Board of Directors.  However, these procedures and controls have not been formalized in its entirety by the end of the first quarter.  After quarter end, management completed its assessment of internal controls over accounts receivables and formalized its newly developed policies and procedures.

 

PART II OTHER INFORMATION

 

Item 1.                       Legal Proceedings

 

In the normal course of business, we may become involved in litigation or in settlement proceedings relating to claims arising out of our operations. Except as described below, we are not a party to any legal proceedings, the adverse outcome of

 

11



 

which, individually or in the aggregate, could have a material adverse effect on our business, financial condition and results of operations.

 

Kirk, et al v. Precis, Inc. and David May

 

On September 8, 2003, the case styled “Robert Kirk, Individually and D/B/A US Asian Advisors, LLC, Eugene M. Kennedy, P.A., Stewart & Associates, CPA’s, P.A. and Kimberly Decamp, Plaintiffs vs. Precis, Inc. and David May, Defendants” was initiated in the District Court of Tarrant County, Texas, Case No. 236 201 468 03. The plaintiffs Robert Kirk (doing business as US Asian Advisors, LLC or U.S. Asian Capital Investors, LLC and recently convicted of securities fraud and related crimes), Kimberly Decamp and Stewart & Associates, CPA’s, P.A. hold warrants exercisable for the purchase of 9,000, 48,000 and 4,000 shares, respectively, of our common stock for $9.00 per share on or before February 8, 2005. The plaintiffs Eugene M. Kennedy, P.A. and Kimberly Decamp hold stock options that expired on June 30, 2003, and that were exercisable for 15,000 and 170,000 shares, respectively, of our common stock for $9.37 per share. David May was our Secretary and Vice President and General Counsel through January 5, 2004.

 

Plaintiffs Eugene M. Kennedy, P.A. (Eugene M. Kennedy is a member of the Florida bar association and a practicing attorney) and Ms. Decamp (the sister of Mr. Kirk) at no time presented the stock option agreements evidencing the stock options and payment of the exercise price of the stock options, $140,550 and $1,592,900, respectively, as required pursuant to the terms of the stock option agreements for exercise. Furthermore, Plaintiffs Robert Kirk, Kimberly Decamp and Stewart & Associates, CPA’s, P.A. at no time tendered the certificates evidencing the warrants and the completed and executed Form of Subscription (Cashless Exercise) required for exercise of the warrants without payment of the exercise price of those warrants.

 

The plaintiffs allege that they were not allowed to exercise their stock options and warrants in May of 2003 due to actions and inactions of Mr. May and that these actions and inactions constitute fraud, misrepresentation, negligence and legal malpractice. All communications with Mr. May were through the plaintiffs’ broker, Burt Martin Arnold Securities, Inc. Plaintiffs are seeking damages equal to the difference between the exercise price of the stock options or warrants and the market value of our common stock on May 7, 2002 (presumably the closing sale price of $15.75) or an aggregate sum of $1,592,050, plus exemplary damages and costs.

 

An answer has been filed setting forth the Company’s position that the plaintiff failed to follow the procedures required by the warrant and stock option agreements for effective exercise. Although we believe the plaintiffs’ claims are without merit, this case, for the second time, is scheduled for trial in May 2005, and, as of the date of this report, we cannot provide any assurance regarding the outcome or results of this litigation.

 

Zermeno v. Precis

 

The case styled “Manuela Zermeno, individually and on behalf of the general public; and Juan A. Zermeno, individually and on behalf of the general public vs. Precis, Inc., an Oklahoma corporation and Does 1 through 100, inclusive” was filed on August 14, 2003 in the Superior Court of the State of California for the county of Los Angeles.

 

A second case styled “California Foundation for Business Ethics, Inc., a California non-profit corporation, v Precis, Inc., and Does 1 through 100, inclusive” was filed on September 9, 2003, in the Superior Court of the State of California for the county of Los Angeles.

 

The two above cases were removed to the United States District Court for the Central District of California and consolidated, by order of the court, on December 4, 2003.

 

The Zermeno plaintiffs are former members of the Care Entrée™ discount health care program who allege that they (for themselves and for the general public) are entitled to injunctive, declaratory, and equitable relief. Plaintiffs’ First Amended Complaint set forth three distinct claims under California law. Plaintiffs’ first cause of action alleged that the operation of the Care Entrée™ program by Defendants Precis, Inc. and The Capella Group, Inc. violates Health and Safety Code § 445 (“Section 445”), which governs medical referral services. Next, Plaintiffs alleged that they are entitled to damages under Civil Code §§ 1812.119 and 1812.123, which are part of the broader statutory scheme governing the operation of discount buying organizations, Civil Code 1812. 100 et. seq. (“Section 1812.100”). Plaintiffs’ third cause of action sought relief under Business and Professions Code § 17200, California’s Unfair Competition Law.

 

We have fully settled all the claims brought by the California Foundation for Business Ethics, Inc.  With the Zermeno plaintiffs, we have settled the causes of action related to Civil Code §§ 1812.119 and 1812.123.  The claim related to Section 445 and the related claim under Section 17200 remain pending and have been assigned to the Superior Court of

 

12



 

California, Los Angeles County under case number BC 300788.  A negative result in this case would have a material affect on our financial condition and would limit our ability (and that of other medical discount cards) to do business in California.

 

We believe that we have complied with all applicable statues and regulations in the state of California.  Although we believe the Plaintiffs’ claims are without merit, this remaining matter in the case remains pending, and, as of the date of this report, we cannot provide any assurance regarding the outcome or results of this litigation.

 

State of Texas v. The Capella Group, Inc. et al

 

The State of Texas filed a lawsuit against our subsidiary, The Capella Group, Inc. d/b/a Care Entrée and Equal Access Health, Inc. (including various names under which Equal Access Health, Inc. does business), on April 28, 2005.  The lawsuit alleges that Care Entrée directly and through at least one other party that resells Care Entrée’s services to the public, violated certain provisions of the Texas Deceptive Trade Practices – Consumer Protection Act.  The lawsuit seeks, among other things, injunctive relief, monetary penalties and restitution.  The Company believes that the allegations are without merit and will vigorously defend the lawsuit.  The lawsuit was filed in the 98th District Court of Travis County, Texas, under case number GV501264.  We believe that the allegations are without merit and intend on defending the lawsuit.  Care Entrée has always insisted that its programs be sold in an honest and forthright manner and has worked to protect the interests of consumers in Texas and around the country.  Findings against the Company in the lawsuit could result in a material adverse effect on our financial condition and on our operations.  Because the lawsuit is in its earliest stages, we cannot provide any assurance regarding the outcome or results of this litigation.

 

Equal Access Health, Inc. v. The Capella Group, Inc.

 

On February 18, 2005, Equal Access Health, Inc. (“EAH”) filed a lawsuit against our subsidiary, The Capella Group, Inc.  We had an agreement with EAH since 2002, whereby EAH would resell our services under its own name, under our typical private label arrangements.  The lawsuit alleges that we breached our agreement with EAH, fraudulently induced EAH into not terminating its agreement with us when it had the opportunity to do so, and improperly withheld $25,000 from EAH.  We believe we have valid counterclaims against EAH for its breaching of our contract.  We were in settlement discussion with EAH through April 5, 2005, and had agreed to allow EAH to sell the EAH members for whom we provide services to a third party.  The agreed-upon settlement did not involve any exchange of money.  EAH’s sale of those members was not consummated as expected and we had to begin new settlement discussion on April 5, 2005.  EAH is a co-defendant in the lawsuit against us by the State of Texas.  Because some of the concerns of the State of Texas relate to EAH’s activities, we may seek indemnification from EAH for damages that we incur as a result of the lawsuit brought against us by the State of Texas.  The lawsuit by EAH is pending in the 236th Judicial District Court of Tarrant County, Texas under case number 236-210082-05.  Findings against us in the lawsuit could result in a material adverse effect on our financial condition and on our operations.  Because the lawsuit is in its earliest stages, we cannot provide any assurance regarding the outcome or results of this litigation.

 

Item 2.                       Unregistered Sales of Equity Securities and Use of Proceeds

 

(a)                         None.

 

(b)                        None.

 

13



 

(c) Repurchases of the Company’s Treasury Stock During the First Quarter of 2005

 

On July 8, 2004, the Company’s Board of Directors authorized the repurchase of up to 500,000 shares of our common stock through open market or private purchase transactions over the next year depending on prevailing market conditions.  As of the filing of this report we have purchased 473,423 shares under this authorization for a total consideration of $1,018,525 at a weighted average price of $2.15 per share. During the first quarter of 2005 and through May 13, 2005, repurchases of shares were as follows:

 

Month

 

Shares
Purchased

 

Weighted
Avg. Stock
Price/Share

 

Cumulative
Number of
Shares
Purchased

 

Number of
Shares That
May Yet Be
Purchased
under the Plan

 

January

 

15,412

 

$

2.09

 

271,358

 

228,642

 

February

 

29,115

 

$

2.23

 

300,473

 

199,527

 

March

 

35,450

 

$

1.91

 

335,923

 

164,077

 

April

 

32,600

 

$

1.77

 

368,523

 

131,477

 

May

 

104,900

 

$

1.09

 

473,423

 

26,577

 

 

(d)                        None.

 

Item 3.        Defaults Upon Senior Securities

 

None.

 

Item 4.        Submission of Matters to a Vote of Security Holders

 

None.

 

Item 5.        Other Information

 

None.

 

14



 

Item 6.                       Exhibits and Reports on Form 8-K

 

(a) Exhibits:

 

Exhibit
No.

 

Description

 

 

 

3.1

 

Registrant’s Certificate of Incorporation, incorporated by reference to Exhibit 3.2 of Registrant’s Form 8-K/A filed with the Commission on June 25, 2001.

 

 

 

3.2

 

Registrant’s Bylaws as amended and restated on April 30, 2003 incorporated by reference to Exhibit 3.2 of Registant's Form 10-Q filed with the Commission on May 14, 2003.

 

 

 

4.1

 

Form of certificate of the common stock of Registrant is incorporated by reference to Exhibit 1.1 of Amendment to Registration Statement on Form 8-A, as filed with the Commission on July 31, 2001.

 

 

 

4.2

 

Precis SmartCard, Inc. 1999 Stock Option Plan (amended and restated), incorporated by reference to the Schedule 14A filed with the Commission on May 16, 2001.

 

 

 

4.3

 

Precis, Inc. 2002 IMR Stock Option Plan, incorporated by reference to the Schedule 14A filed with the Commission on June 26, 2002.

 

 

 

4.4

 

Precis, Inc. 2002 Non-Employee Stock Option Plan, incorporated by reference to the Schedule 14A filed with the Commission on June 26, 2002.

 

 

 

31.1

 

Certification Pursuant to Rule 13a-14(a) and 15d-14(a) of Judith H. Henkels as President & Chief Executive Officer.

 

 

 

31.2

 

Certification Pursuant to Rule 13a-14(a) and 15d-14(a) of Robert Bintliff as Chief Financial Officer.

 

 

 

32.1

 

Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of Sarbanes-Oxley Act of Judith H. Henkels as President & Chief Executive Officer.

 

 

 

32.2

 

Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of Sarbanes-Oxley Act of Robert Bintliff as Chief Financial Officer.

 

15



 

SIGNATURES:

 

In accordance with the requirements of the Exchange Act, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

PRECIS, INC.

 

(Registrant)

 

 

 

Date:  May 16, 2005

/s/ JUDITH H. HENKELS

 

Judith H. Henkels

 

President & Chief Executive

 

Officer

 

 

Date:  May 16, 2005

/s/ ROBERT BINTLIFF

 

Robert Bintliff

 

Chief Financial Officer

 

16



 

INDEX TO FINANCIAL STATEMENTS

 

Condensed Consolidated Balance Sheets as of March 31, 2005 (unaudited) and December 31, 2004 (audited)

18

 

 

Unaudited Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2005  and 2004

19

 

 

Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended March 31, 2005

20

 

 

Unaudited Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2005 and 2004

21

 

 

Notes to Unaudited Condensed Consolidated Financial Statements

22

 

17



 

PRECIS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in Thousands)

 

 

 

March 31,
2005

 

December 31,
2004

 

 

 

(unaudited)

 

(audited)

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash in trust

 

$

5,349

 

$

4,922

 

Cash and cash equivalents

 

7,918

 

8,283

 

Accounts receivable, net

 

342

 

312

 

Income tax receivable

 

1,013

 

980

 

Inventory

 

166

 

174

 

Prepaid expenses

 

571

 

547

 

 

 

 

 

 

 

Total current assets

 

15,359

 

15,218

 

 

 

 

 

 

 

Fixed assets, net

 

1,874

 

1,989

 

Goodwill

 

22,501

 

21,381

 

Other intangible assets, net

 

1,365

 

1,400

 

Deferred tax asset

 

1,827

 

1,801

 

Other assets

 

173

 

186

 

 

 

 

 

 

 

Total assets

 

$

43,099

 

$

41,975

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

245

 

$

470

 

Accrued commissions

 

608

 

731

 

Accrued consideration on business combination

 

1,120

 

 

Other accrued liabilities

 

1,538

 

1,573

 

Franchise taxes payable

 

537

 

509

 

Members’ liabilities

 

5,349

 

4,922

 

Deferred fees

 

94

 

154

 

Current portion of capital leases

 

400

 

514

 

 

 

 

 

 

 

Total current liabilities

 

9,891

 

8,873

 

 

 

 

 

 

 

Capital lease obligations, net of current portion

 

399

 

78

 

Deferred income taxes

 

655

 

655

 

 

 

 

 

 

 

Total liabilities

 

10,945

 

9,606

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Common stock, $.01 par value, 100,000,000 shares authorized; 12,335,766 issued, and 11,792,170 and 11,872,147 outstanding, respectively

 

123

 

123

 

Additional paid-in capital

 

27,221

 

27,221

 

Accumulated earnings

 

5,656

 

5,707

 

Less: treasury stock (335,923 shares and 255,946 shares, respectively)

 

(846

)

(682

)

Total stockholders’ equity

 

32,154

 

32,369

 

 

 

 

 

 

 

Total liabilities and stockholders’ equity

 

$

43,099

 

$

41,975

 

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

18



 

PRECIS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars in Thousands, except Earnings per Share)

 

 

 

For the Three Months Ended
March 31,

 

 

 

2005

 

2004

 

Revenues

 

$

8,700

 

$

9,946

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

Cost of operations

 

3,109

 

3,301

 

Sales and marketing

 

2,200

 

3,198

 

General and administrative

 

3,485

 

2,329

 

 

 

 

 

 

 

Total operating expenses

 

8,794

 

8,828

 

 

 

 

 

 

 

Operating (loss) income

 

(94

)

1,118

 

 

 

 

 

 

 

Other expenses:

 

 

 

 

 

Interest (income) and expense, net

 

(13

)

29

 

 

 

 

 

 

 

Total other expenses

 

(13

)

29

 

 

 

 

 

 

 

Net (loss) earnings before taxes

 

(81

)

1,089

 

(Benefit) Provision for income taxes

 

(30

)

483

 

 

 

 

 

 

 

Net (loss) earnings

 

(51

)

606

 

 

 

 

 

 

 

Preferred stock dividends

 

 

 

 

 

 

 

 

 

Net (loss) earnings applicable to common stockholders

 

$

(51

)

$

606

 

 

 

 

 

 

 

(Loss) earnings per share:

 

 

 

 

 

Basic

 

$

0.00

 

$

0.05

 

 

 

 

 

 

 

Diluted

 

$

0.00

 

$

0.05

 

 

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

 

 

Basic

 

11,824,255

 

11,864,714

 

 

 

 

 

 

 

Diluted

 

11,824,255

 

11,930,725

 

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

19



 

PRECIS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Dollars in Thousands)

 

 

 

COMMON STOCK

 

Additional

 

Treasury

 

Accumulated

 

 

 

 

 

Shares

 

Amount

 

Paid-in Capital

 

Stock

 

Earnings

 

Total

 

Balance, December 31, 2004 (audited)

 

12,335,766

 

$

123

 

$

27,221

 

$

(682

)

$

5,707

 

$

32,369

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Repurchase of 79,977 common shares

 

 

 

 

(164

)

 

(164

)

Net loss

 

 

 

 

 

(51

)

(51

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, March 31, 2005 (unaudited)

 

12,335,766

 

$

123

 

$

27,221

 

$

(846

)

$

5,656

 

$

32,154

 

 

See Accompanying Notes to Unaudited Condensed Consolidated Financial Statements

 

20



 

PRECIS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in Thousands)

 

 

 

For the Three Months Ended

 

 

 

2005

 

2004

 

Operating activities:

 

 

 

 

 

Net (loss) earnings

 

$

(51

)

$

606

 

Adjustments to reconcile net (loss) earnings to net cash provided by operating activities:

 

 

 

 

 

Depreciation

 

643

 

544

 

Amortization of intangibles

 

35

 

 

Change in allowance for doubtful accounts

 

24

 

(83

)

Changes in assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(54

)

89

 

Income taxes receivable

 

(33

)

(13

)

Notes receivable

 

 

40

 

Inventory

 

8

 

19

 

Prepaid expenses

 

(24

)

32

 

Deferred tax asset

 

(26

)

 

Other assets

 

13

 

(20

)

Accounts payable

 

(225

)

(79

)

Accrued liabilities

 

(158

)

(35

)

Deferred fees

 

(60

)

(153

)

Income taxes payable

 

28

 

496

 

 

 

 

 

 

 

Net cash provided by operating activities

 

120

 

1,443

 

 

 

 

 

 

 

Investing activities:

 

 

 

 

 

Purchase of fixed assets

 

(38

)

(152

)

 

 

 

 

 

 

Net cash used in investing activities

 

(38

)

(152

)

 

 

 

 

 

 

Financing activities:

 

 

 

 

 

Exercise of stock options

 

 

4

 

Payments on capital leases

 

(283

)

(370

)

Purchase of treasury stock

 

(164

)

 

 

 

 

 

 

 

Net cash used in financing activities

 

(447

)

(366

)

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalents

 

(365

)

925

 

 

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

8,283

 

11,088

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

 

$

7,918

 

$

12,013

 

 

 

 

 

 

 

Supplemental disclosure:

 

 

 

 

 

Interest paid

 

$

11

 

$

32

 

 

 

 

 

 

 

Non-cash investing and financing activities:

 

 

 

 

 

Acquisition of fixed assets through issuance of capital leases, net of retirements

 

$

491

 

$

68

 

Accrued cash consideration and stock issuance on business combination

 

$

1,120

 

$

 

Cash-in-trust collected, net of claims paid

 

$

427

 

$

1,251

 

 

See Accompanying Notes to Condensed Consolidated Financial Statements

 

21



 

PRECIS, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1 – Interim Financial Information

 

The accompanying condensed consolidated financial statements are unaudited, but include all adjustments (consisting only of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position at such dates and of the operations and cash flows for the periods then ended. The financial information is presented in a condensed format, and it does not include all of the footnote disclosure normally included in financial statements prepared in accordance with generally accepted accounting principles. Operating results for the three   months ended March 31, 2005 and 2004 are not necessarily indicative of results that may be expected for the entire year.  The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities and reported amounts of revenues and expenses during the reporting periods under consideration.  Actual results could differ materially from such assumptions and estimates.  The accompanying condensed consolidated financial statements and related footnotes should be read in conjunction with the Company’s audited financial statements, included in its December 31, 2004 Form 10-K filed with the Securities and Exchange Commission.

 

Note 2 – Common Stock Options

 

As of March 31, 2005, the Company has three stock-based compensation plans.  The Company applies APB 25 and related interpretations in accounting for its plans.  Under APB 25, compensation for services that a corporation receives through stock-based compensation plans should be measured by the excess, if any, of the quoted market price of the stock at the measurement date less the amount, that the individual is required to pay.  No compensation expense was recorded during the three months ended March 31, 2005 and 2004 related to its stock option plans under APB 25.  If the Company had elected to recognize compensation based on the fair value of the options granted at the grant date as prescribed by “Statement of Financial Accounting Standards No. 123 (“SFAS 123”) Accounting for Stock-Based Compensation”, net earnings and net earnings per share would have decreased as shown in the pro forma amounts below for the three months ended March 31, 2005 and 2004.

 

 

 

For the Three Months Ended
March 31,

 

(Dollars in Thousands)

 

2005

 

2004

 

Net (loss) earnings applicable to stockholders

 

$

(51

)

$

606

 

Deduct: Total stock-based compensation expense determined under fair value based method for all awards, net of related tax effects

 

(79

)

(32

)

 

 

 

 

 

 

Pro forma net (loss) earnings

 

$

(130

)

$

574

 

 

 

 

 

 

 

(Loss) Earnings per share:

 

 

 

 

 

Basic - as reported

 

$

0.00

 

$

0.05

 

 

 

 

 

 

 

Basic - pro forma

 

$

0.00

 

$

0.05

 

 

 

 

 

 

 

Diluted - as reported

 

$

0.00

 

$

0.05

 

 

 

 

 

 

 

Diluted - pro forma

 

$

0.00

 

$

0.05

 

 

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions used for grants: weighted average risk free interest rate of 3.94% (March 31, 2004 – 4.49%); no dividend yield; volatility of 72% (March 31, 2004 – 86%); and expected life less than five years.  The fair values of the options were based on the difference between the present value of the exercise price of the option and the estimated fair value price of the common share.

 

The intent of the Black-Scholes option valuation model is to provide estimates of fair values of traded options that have no vesting restrictions and are fully transferable.  Option valuation models require the use of highly subjective assumptions including expected stock price volatility.  The Company has utilized the Black-Scholes method to produce the pro forma disclosures required under SFAS 123.  In management’s opinion, existing valuation models do not necessarily provide a reliable single measure of the fair value of its employee stock options because the Company’s employee stock options have significantly different characteristics from those of traded options and because changes in the subjective input assumptions can materially affect the fair value estimate.  The effects of applying SFAS 123 in this pro forma are not indicative of future amounts.

 

22



 

Note 3 – Earnings Per Share

 

The Company’s earnings per share data was computed as follows:

 

 

 

For the Three Months Ended
March 31,

 

(Dollars in Thousands)

 

2005

 

2004

 

 

 

 

 

 

 

Basic (loss) earnings per share

 

 

 

 

 

Net (loss) earnings

 

$

(51

)

$

606

 

Weighted average number of common shares outstanding during the period.

 

11,824,255

 

11,864,714

 

Basic (loss) earnings per share

 

$

0.00

 

$

0.05

 

 

 

 

 

 

 

Diluted (loss) earnings per share

 

 

 

 

 

Net (loss) earnings

 

$

(51

)

$

606

 

Weighted average number of common shares outstanding during the period

 

11,824,255

 

11,864,714

 

Stock options(1)

 

 

66,011

 

Weighted average number of shares outstanding during the period—assumed conversion (1)

 

11,824,255

 

11,930,725

 

Diluted (loss) earnings per share (1)

 

$

0.00

 

$

0.05

 

 


(1)                                 For the quarter ended March 31, 2005, 16,391 in-the-money shares related to outstanding stock options were not included in the calculation of fully diluted earnings per share because the inclusion would have been anti-dilutive due to a net loss for that period.  The number of stock options and warrants that were considered out-of-the-money for purposes of the diluted earnings per share calculation for the three months ended March 31, 2005 and 2004 was 1,449,764 and 655,366, respectively

 

Note 4 – Contingencies

 

Kirk, et al v. Precis, Inc. and David May

 

On September 8, 2003, the case styled “Robert Kirk, Individually and D/B/A US Asian Advisors, LLC, Eugene M. Kennedy, P.A., Stewart & Associates, CPA’s, P.A. and Kimberly Decamp, Plaintiffs vs. Precis, Inc. and David May, Defendants” was initiated in the District Court of Tarrant County, Texas, Case No. 236 201 468 03. The plaintiffs Robert Kirk (doing business as US Asian Advisors, LLC or U.S. Asian Capital Investors, LLC and recently convicted of securities fraud and related crimes), Kimberly Decamp and Stewart & Associates, CPA’s, P.A. hold warrants exercisable for the purchase of 9,000, 48,000 and 4,000 shares, respectively, of our common stock for $9.00 per share on or before February 8, 2005. The plaintiffs Eugene M. Kennedy, P.A. and Kimberly Decamp hold stock options that expired on June 30, 2003, and that were exercisable for 15,000 and 170,000 shares, respectively, of our common stock for $9.37 per share. David May was our Secretary and Vice President and General Counsel through January 5, 2004.

 

Plaintiffs Eugene M. Kennedy, P.A. (Eugene M. Kennedy is a member of the Florida bar association and a practicing attorney) and Ms. Decamp (the sister of Mr. Kirk) at no time presented the stock option agreements evidencing the stock options and payment of the exercise price of the stock options, $140,550 and $1,592,900, respectively, as required pursuant to the terms of the stock option agreements for exercise. Furthermore, Plaintiffs Robert Kirk, Kimberly Decamp and Stewart & Associates, CPA’s, P.A. at no time tendered the certificates evidencing the warrants and the completed and executed Form of Subscription (Cashless Exercise) required for exercise of the warrants without payment of the exercise price of those warrants.

 

The plaintiffs allege that they were not allowed to exercise their stock options and warrants in May of 2003 due to actions and inactions of Mr. May and that these actions and inactions constitute fraud, misrepresentation, negligence and legal malpractice. All communications with Mr. May were through the plaintiffs’ broker, Burt Martin Arnold Securities, Inc. Plaintiffs are seeking damages equal to the difference between the exercise price of the stock options or warrants and the market value of our common stock on May 7, 2002 (presumably the closing sale price of $15.75) or an aggregate sum of $1,592,050, plus exemplary damages and costs.

 

23



 

An answer has been filed setting forth the Company’s position that the plaintiff failed to follow the procedures required by the warrant and stock option agreements for effective exercise. Although we believe the plaintiffs’ claims are without merit, this case, for the second time, is scheduled for trial in May 2005, and, as of the date of this report, we cannot provide any assurance regarding the outcome or results of this litigation.

 

Zermeno v. Precis

 

The case styled “Manuela Zermeno, individually and on behalf of the general public; and Juan A. Zermeno, individually and on behalf of the general public vs. Precis, Inc., an Oklahoma corporation and Does 1 through 100, inclusive” was filed on August 14, 2003 in the Superior Court of the State of California for the county of Los Angeles.

 

A second case styled “California Foundation for Business Ethics, Inc., a California non-profit corporation, v Precis, Inc., and Does 1 through 100, inclusive” was filed on September 9, 2003, in the Superior Court of the State of California for the county of Los Angeles.

 

The two above cases were removed to the United States District Court for the Central District of California and consolidated, by order of the court, on December 4, 2003.

 

The Zermeno plaintiffs are former members of the Care Entrée™ discount health care program who allege that they (for themselves and for the general public) are entitled to injunctive, declaratory, and equitable relief. Plaintiffs’ First Amended Complaint set forth three distinct claims under California law. Plaintiffs’ first cause of action alleged that the operation of the Care Entrée™ program by Defendants Precis, Inc. and The Capella Group, Inc. violates Health and Safety Code § 445 (“Section 445”), which governs medical referral services. Next, Plaintiffs alleged that they are entitled to damages under Civil Code §§ 1812.119 and 1812.123, which are part of the broader statutory scheme governing the operation of discount buying organizations, Civil Code 1812. 100 et. seq. (“Section 1812.100”). Plaintiffs’ third cause of action sought relief under Business and Professions Code § 17200, California’s Unfair Competition Law.

 

We have fully settled all the claims brought by the California Foundation for Business Ethics, Inc.  With the Zermeno plaintiffs, we have settled the causes of action related to Civil Code §§ 1812.119 and 1812.123.  The claim related to Section 445 and the related claim under Section 17200 remain pending and have been assigned to the Superior Court of California, Los Angeles County under case number BC 300788.  A negative result in this case would have a material affect on our financial condition and would limit our ability (and that of other medical discount cards) to do business in California.

 

We believe that we have complied with all applicable statues and regulations in the state of California.  Although we believe the Plaintiffs’ claims are without merit, this remaining matter in the case remains pending, and, as of the date of this report, we cannot provide any assurance regarding the outcome or results of this litigation.

 

State of Texas v. The Capella Group, Inc. et al

 

The State of Texas filed a lawsuit against our subsidiary, The Capella Group, Inc. d/b/a Care Entrée on April 28, 2005.  The lawsuit alleges that Care Entrée directly and through at least one other party that resells Care Entrée’s services to the public, violated certain provisions of the Texas Deceptive Trade Practices – Consumer Protection Act.  The lawsuit seeks, among other things, injunctive relief, monetary penalties and restitution.  The Company believes that the allegations are without merit and will vigorously defend the lawsuit.  The lawsuit was filed in the 98th District Court of Travis County, Texas, under case number GV501264.  We believe that the allegations are without merit and intend on defending the lawsuit.  Care Entrée has also insisted that its programs be sold in an honest and forthright manner and has worked to protect the interests of consumers in Texas and around the country.  Findings against the Company in the lawsuit could result in a material adverse effect on our financial condition and on our operations.  Because the lawsuit is in its earliest stages, we cannot provide any assurance regarding the outcome or results of this litigation.

 

Equal Access Health v. The Capella Group, Inc.

 

On February 18, 2005, Equal Access Health, Inc. (“EAH”) filed a lawsuit against our subsidiary, The Capella Group, Inc.  We had an agreement with EAH since 2002, whereby EAH would resell our services under its own name, under our typical private label arrangements.  The lawsuit alleges that we breached our agreement with EAH, fraudulently induced EAH into not terminating its agreement with us when it had the opportunity to do so, and improperly withheld $25,000 from EAH.  We believe we have valid counterclaims against EAH for its breaching of our contract.  We were in settlement discussion with EAH through April 5, 2005, and had agreed to allow EAH to sell the EAH members for whom we provide services to a third party.  The agreed-upon settlement did not involve any exchange of money.  EAH’s sale of those members was not consummated as expected and we had to begin new settlement discussion on April 5, 2005.  EAH is a co-defendant in the lawsuit against us by the State of Texas.  Because some of the concerns of the State of Texas relate to EAH’s activities,

 

24



 

we may seek indemnification from EAH for damages that we incur as a result of the lawsuit brought against us by the State of Texas.  The lawsuit by EAH is pending in the 236th Judicial District Court of Tarrant County, Texas under case number 236-210082-05.  Findings against us in the lawsuit could result in a material adverse effect on our financial condition and on our operations.  Because the lawsuit is in its earliest stages, we cannot provide any assurance regarding the outcome or results of this litigation.

 

The Company has accrued $187,500 as of March  31, 2005 to provide for costs of defense and possible settlement of pending and threatened litigation, including those matters described above. The Company accrues the cost of defending and settling pending and threatened claims and litigation, including legal fees to be incurred in such defense, when in its judgment such costs are estimable and probably will be incurred.

 

In January 1999, the former parent of Foresight, Inc., Universal Marketing Services, Inc., purchased the outstanding common stock of Foresight, Inc. for $4,540,000. Universal Marketing Services agreed to indemnify the former owners of the common stock of Foresight, Inc. for the increase in federal income taxes and any applicable penalties to the extent that $4,540,000 of the purchase price does not qualify for long-term capital gain treatment. These former shareholders reported $4,540,000 of the purchase price as long-term capital gain. In connection with the Company’s merger- acquisition of Foresight, Inc., the Company assumed the indemnification obligation of Universal Marketing Services. Upon examination, the Internal Revenue Service may take the position that a portion of the $4,540,000 should be classified as ordinary income taxable at the maximum federal income tax rate of 39.6% rather than the long-term capital gain 20% rate. In the event the Internal Revenue Service successfully asserts that long-term capital gain classification was improper, the Company will be required to indemnify the former shareholders.

 

The Company has an unused letter of credit in the amount of $1,500,000 obtained on commercial terms. The letter of credit is due to expire on June 6, 2005.

 

On June 18, 2004, the Company completed its acquisition of Access HealthSource, Inc. (“Access”), a third party administrator, from National Center for the Employment of the Disabled for a purchase price of $3,666,000, consisting of 488,486 shares of common stock of the Company valued at $1,400,000 ($2.87 per share), and $2,000,000 in cash and acquisition cost of investment banking, valuation and legal and accounting fees of $266,000.  In addition to the purchase price consideration, there is a contingency payout should the earnings before interest, taxes, depreciation and amortization (“EBITDA”) of Access reach certain amounts after the closing of the transaction and before December 31, 2006.  EBITDA, while not considered a measure under accounting principles generally accepted in the United States of America, is the financial measurement utilized for the basis of the contingency payout and additional purchase price payments are dependent on Access achieving certain EBITDA levels.  The maximum amount of the consideration that may be paid to the seller of Access, including the closing date purchase price consideration and investment banking, valuation and legal and accounting fees, is $9,773,500.  The amount of contingency payments and common stock deliveries based upon EBDITA through December 31, 2006, will be based upon a 3.22 multiple of EBITDA of Access determined on a quarterly basis, with effective adjustments as of December 31, 2004, 2005 and 2006.  During the first quarter of 2005, Access’ performance to date resulted in an obligation to convey cash payments of $560,000 plus the issuance of 320,473 common shares valued at $560,000 (based upon the average trading price for the last ten days in March 2005) which were conveyed in April.  These amounts are reported as a current liability in the accompanying balance sheet.  The Company expects that Access will further achieve those EBITDA levels and that, as a result, additional contingent payouts will be made. However, the amount of payouts through December 31, 2006 cannot be estimated at this time. The contingency payout will be accounted for as a decrease in the Company’s cash and cash equivalents for the amount paid, an increase to stockholders’ equity for the fair value issued and a corresponding increase in goodwill for the value of the cash paid and stock issued.

 

Note 5—Segmented Information

 

The Company discloses segment information in accordance with SFAS No. 131, “Disclosure About Segments of an Enterprise and Related Information,” which requires companies to report selected segment information on a quarterly basis and to report certain entity-wide disclosures about products and services, major customers, and the material countries in which the entity holds assets and reports revenues. The Company has four reportable segments: healthcare savings cards, self-funded employer healthcare administration, non-healthcare membership programs and financial services. The Company’s reportable segments are strategic divisions that offer different services and are managed separately as each division requires different resources and marketing strategies.  Our healthcare savings card segment, our largest segment, offers savings on healthcare services to persons who are un-insured, under-insured, or who have elected to purchase only high deductible or limited benefit medical insurance policies, by providing access to the same preferred provider organizations (PPOs) that are utilized by many insurance companies and employers who self-fund at least a portion of their employees’ healthcare risk. These programs are sold primarily through a network marketing strategy.  Our self-funded employer healthcare administration segment provides a wide range of healthcare claims administration services and other cost containment procedures that are frequently required by governments and other large employers who have chosen to self

 

25



 

fund their healthcare benefits requirements.  Our non-healthcare membership division offers non-healthcare related membership programs for rental-purchase companies, financial organizations, employer groups, retailers and association-based organizations. Substantially all of our non-healthcare related membership service programs are offered and sold at retail by clients engaged in the rental-purchase industry.  Our financial services segment provides high deductible and scheduled benefit insurance policies, life insurance and annuities and health savings accounts, healthcare reimbursement arrangements and medical and dependent care flexible spending accounts.

 

The accounting policies of the segments are consistent with those described in the summary of significant accounting policies in Note 2 of the Company’s audited financials, included in its December 31, 2004 Form 10K, intersegment sales are not material and all intersegment transfers are eliminated. During 2004, the Company increased the number of segments from one to four, excluding its corporate activities.

 

No one customer represents more than 5% of the Company’s overall revenue. Therefore, the Company does not believe it has a material reliance on any one customer. The Company operates in substantially all of the fifty states in the U.S. but not in any foreign countries.

 

The Company evaluates segment performance based on revenues and income before provision for income taxes. The Company does not allocate income taxes or unusual items to the segments. The following table summarizes segment information:

 

First Quarter 2005 (in 000’s)

 

Healthcare
Savings

 

Employer
Healthcare

 

Membership
Programs

 

Financial
Services

 

Corporate

 

Total

 

Revenue

 

$

6,356

 

$

2,010

 

$

207

 

$

127

 

$

 

$

8,700

 

Income (Loss) before Taxes

 

245

 

467

 

(259

)

(298

)

(236

)

(81

)

Interest Expense (Income)

 

 

 

 

 

(13

)

(13

)

Depreciation and Amortization

 

619

 

53

 

1

 

5

 

 

678

 

Taxes (Benefit) (1)

 

 

 

 

 

(30

)

(30

)

Assets Acquired, net of disposals

 

520

 

9

 

 

 

 

529

 

Intangible Assets (1)

 

 

 

 

 

23,866

 

23,866

 

Assets Held

 

9,852

 

1,755

 

1,290

 

78

 

30,124

 

43,099

 

 

First Quarter 2004 (in 000’s)

 

Healthcare
Savings

 

Employer
Healthcare

 

Membership
Programs

 

Financial
Services

 

Corporate

 

Total

 

Revenue

 

$

9,583

 

$

 

$

269

 

$

94

 

$

 

$

9,946

 

Income (Loss) before Taxes

 

1,813

 

 

(193

)

(209

)

(322

)

1,089

 

Interest Expense (Income)

 

 

 

 

 

29

 

29

 

Depreciation and Amortization

 

538

 

 

3

 

3

 

 

544

 

Taxes (1)

 

 

 

 

 

483

 

483

 

Assets Acquired, net of disposals

 

189

 

 

12

 

19

 

 

220

 

Goodwill

 

 

 

 

 

21,077

 

21,077

 

Assets Held

 

10,347

 

 

1,570

 

62

 

30,620

 

42,599

 

 


(1)          – Intangible assets and income tax expense (benefit) are not allocated to the assets and operations of the related segment.

 

26